The risk of severe illness and death from COVID-19 among certain sub-groups of the most clinically high-risk patients remained high, despite vaccination, new analysis has found.
New results from the landmark OCTAVE (Observational Cohort Trial-T-ce...
9 months ago
A new US study has further optimised genome editing technology which could help to cure sickle cell disease (SCD) and beta thalassaemia.
Scientists at St. Jude Children’s Research Hospital and the Broad Institute of MIT and Harvard, USA, used aden...
9 months ago
